Cosmos Health | 8-K: Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
Apr 19 17:05 ET
Cosmos Health | NT 10-K: Others
Apr 2 16:37 ET
Cosmos Health | 8-K: Cosmos Health Receives a Non-Compliance Letter from Nasdaq and Company Defines Policies and Procedures for Related Party Transactions
Mar 22 16:30 ET
Cosmos Health | 424B3: Prospectus
Mar 7 16:37 ET
Cosmos Health | 424B3: Prospectus
Feb 29 16:41 ET
Cosmos Health | 4: Statement of changes in beneficial ownership of securities-Officer Siokas Grigorios
Feb 21 10:26 ET
Cosmos Health | 424B3: Prospectus
Feb 15 16:11 ET
Cosmos Health | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
Feb 14 15:38 ET
Cosmos Health | EFFECT: Others
Feb 9 06:04 ET
Cosmos Health | CORRESP: CORRESP
Feb 6 12:03 ET
Cosmos Health | UPLOAD: Others
Feb 5 12:03 ET
Cosmos Health | S-3: Registration statement for specified transactions by certain issuers
Jan 29 17:20 ET
Cosmos Health | 8-K: Cosmos Health Announces Acquisition of Licenses and Rights to 10 Generic Drugs for €3.2 Million
Jan 22 00:00 ET
Cosmos Health | 8-K/A: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement (Amendment)
Dec 29, 2023 00:00 ET
Cosmos Health | 8-K: Cosmos Health Set for Substantial Growth from Acquisitions Completed in 2023 and Entered into a Warrant Exchange Agreement
Dec 29, 2023 00:00 ET
Cosmos Health | 4: Statement of changes in beneficial ownership of securities-Director Aslidis Anastasios
Dec 22, 2023 16:05 ET
Cosmos Health | 8-K: Cosmos Health Board of Directors Adopted a Executive Compensation Clawback Policy
Nov 28, 2023 16:05 ET
Cosmos Health | 8-K: Cosmos Health Reports Q3 2023 Results
Nov 22, 2023 09:30 ET
Cosmos Health: Q3 2023 Earnings Report
Nov 20, 2023 16:05 ET
Cosmos Health | NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Nov 14, 2023 16:00 ET
No Data
No Data